Trial
NCT04051047
Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
University of Colorado, Denver
Condition
Glial Tumor of Brain
Intervention
Gemcitabine
Why stopped
Withdrawn by Principal Investigator
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-27